Dr Agarwal’s Eye Hospital Ltd: 205 Doctors, 17% Patient Growth – Seeing Profits Clearly or Just Eye Wash?

1. At a Glance

Dr Agarwal’s Eye Hospital is that South Indian legend your relatives swear by—“Beta, go to Dr Agarwal, they’ll fix your cataract faster than your Jio recharge.” With ~205 doctors, 1,133 staff, and growing like an Ola driver’s chai bill, the hospital chain has become a Tamil Nadu heavyweight in eye care. FY24 saw 17% growth in patients, cataract revenues up 24%, and 36 new vision centers. But while the clinics shine bright, the real spectacle is the promoter group raising $80 Mn from Temasek and TPG Growth to build a 300+ center empire.

2. Introduction

Let’s get one thing clear: India is ageing faster than iPhone launches. With cataracts, glaucoma, and “Zoom meeting-induced dry eyes” becoming household problems, the ₹20,000 Cr+ Indian ophthalmology market is buzzing. Into this market, Dr Agarwal’s Eye Hospital Ltd sits like Rajinikanth in a white coat—big brand recall, premium services, and a desi mix of hospital + optical shops + pharma counters.

This isn’t just a hospital—it’s a retail play. Surgeries (especially cataracts) make money, but the real gravy is in product sales: opticals (frames & lenses), eye drops, and those overpriced contact lenses we all lose in the sink. With 24% of revenues coming from product sales, this is Apollo + Titan Eye+ in one.

The group is quietly replicating a playbook: dominate Tamil Nadu, then expand into Andhra, Kerala, Rajasthan, and beyond. With a Center of Excellence opening in Chennai in FY25 and 300+ centers targeted in 3 years, Agarwal’s is going pan-India. The question is: can they keep quality sharp, or will they go the Fortis Healthcare way (diluted by scale)?

3. Business Model (WTF Do They Even Do?)

Dr Agarwal’s makes money from two buckets:

1) Services (~76% of revenue)

• Surgeries (83%) → mostly cataract, but also LASIK, retina, cornea, squint corrections.
• Treatments/Investigations (12%) → diagnostic imaging, eye scans, etc.
• Consultation fees (5%) → your ₹700 “come back after a week” doctor visit.

2) Products (~24% of revenue)

• Optical sales (64%) → frames, glasses, lenses (the Titan Eye+ angle).
• Pharma (33%) → drops, ointments, gels.
• Contact lenses (3%) → recurring business from careless teenagers.

Extra juice:

• Vision centers in Tier-2/3 → low-cost hubs that funnel patients